Terms: = Sarcomas AND RHOA, ENSG00000067560, 387, ARHA, RhoA, RHOH12, RHO12, ARH12, Rho12 AND Treatment
40 results:
1. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
[TBL] [Abstract] [Full Text] [Related]
2. Health related Quality of Life over time in German sarcoma patients. An analysis of associated factors - results of the PROSa study.
Eichler M; Hentschel L; Singer S; Hornemann B; Richter S; Hofbauer C; Hohenberger P; Kasper B; Andreou D; Pink D; Jakob J; Grützmann R; Fung S; Wardelmann E; Arndt K; Hermes-Moll K; Schoffer O; Fried M; Jambor HK; Weitz J; Schaser KD; Bornhäuser M; Schmitt J; Schuler MK
Front Endocrinol (Lausanne); 2023; 14():1166838. PubMed ID: 37711899
[TBL] [Abstract] [Full Text] [Related]
3. 7,8-Dihydroxy-3-(4'-hydroxyphenyl)coumarin inhibits invasion and migration of osteosarcoma cells.
Sugiyama Y; Nakamura S; Tokuda Y; Nakano M; Hattori Y; Nishiguchi H; Toda Y; Hosogi S; Yamashita M; Tashiro K; Ashihara E
Biochem Biophys Res Commun; 2023 Jan; 638():200-209. PubMed ID: 36462494
[TBL] [Abstract] [Full Text] [Related]
4. Upregulation of KLHL17 promotes the proliferation and migration of non-small cell lung cancer by activating the Ras/MAPK signaling pathway.
Liu Z; Zhao M; Jiang X; Zhang Y; Zhang S; Xu Y; Ren H; Su H; Wang H; Qiu X
Lab Invest; 2022 Dec; 102(12):1389-1399. PubMed ID: 35978057
[TBL] [Abstract] [Full Text] [Related]
5. Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and rhoa.
Wang J; Yuan L; Xu X; Zhang Z; Ma Y; Hong L; Ma J
Cell Death Dis; 2021 Dec; 12(12):1148. PubMed ID: 34893584
[TBL] [Abstract] [Full Text] [Related]
6. High-throughput transcriptomic and proteomic profiling of mesenchymal-amoeboid transition in 3D collagen.
Čermák V; Gandalovičová A; Merta L; Harant K; Rösel D; Brábek J
Sci Data; 2020 May; 7(1):160. PubMed ID: 32461585
[TBL] [Abstract] [Full Text] [Related]
7. [Application of multimode MRI in prediction of nuclear grade of clear cell renal cell carcinoma].
Li Q; Liu ZH; Wang HY; Huang QB; Guo AT; Zhang XJ; Bai X; Ye HY
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(23):1767-1772. PubMed ID: 31207684
[No Abstract] [Full Text] [Related]
8. Fisetin Suppresses Human Osteosarcoma U-2 OS Cell Migration and Invasion
Chen JK; Peng SF; Lai KC; Liu HC; Huang YP; Lin CC; Huang AC; Chueh FS; Chung JG
In Vivo; 2019; 33(3):801-810. PubMed ID: 31028200
[TBL] [Abstract] [Full Text] [Related]
9. MiR-144 Inhibits Tumor Growth and Metastasis in Osteosarcoma via Dual-suppressing rhoa/ROCK1 Signaling Pathway.
Liu JL; Li J; Xu JJ; Xiao F; Cui PL; Qiao ZG; Chen XD; Tao WD; Zhang XL
Mol Pharmacol; 2019 Apr; 95(4):451-461. PubMed ID: 30674565
[TBL] [Abstract] [Full Text] [Related]
10. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
[TBL] [Abstract] [Full Text] [Related]
11. Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of rhoa-AMPK/p38 MAPK Signaling in Antitumor Activity.
Kamel WA; Sugihara E; Nobusue H; Yamaguchi-Iwai S; Onishi N; Maki K; Fukuchi Y; Matsuo K; Muto A; Saya H; Shimizu T
Mol Cancer Ther; 2017 Jan; 16(1):182-192. PubMed ID: 27799356
[TBL] [Abstract] [Full Text] [Related]
12. FKBP14 overexpression contributes to osteosarcoma carcinogenesis and indicates poor survival outcome.
Huang Z; Li J; Du S; Tang Y; Huang L; Xiao L; Tong P
Oncotarget; 2016 Jun; 7(26):39872-39884. PubMed ID: 27223089
[TBL] [Abstract] [Full Text] [Related]
13. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of treatment Success After Liver Metastasis Ablation.
Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
[TBL] [Abstract] [Full Text] [Related]
14. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma.
Cai X; Liu Y; Yang W; Xia Y; Yang C; Yang S; Liu X
J Orthop Res; 2016 Jun; 34(6):932-41. PubMed ID: 26575981
[TBL] [Abstract] [Full Text] [Related]
15. Elevation of soluble intercellular adhesion molecule-1 levels, but not angiopoietin 2, in the plasma of human immunodeficiency virus-infected African women with clinical Kaposi sarcoma.
Graham SM; Rajwans N; Richardson BA; Jaoko W; McClelland RS; Overbaugh J; Liles WC
Am J Trop Med Hyg; 2014 Oct; 91(4):705-8. PubMed ID: 25002294
[TBL] [Abstract] [Full Text] [Related]
16. Three-dimensional spatial configuration of tumour cells confers resistance to chemotherapy independent of drug delivery.
Tan PH; Chia SS; Toh SL; Goh JC; Nathan SS
J Tissue Eng Regen Med; 2016 Aug; 10(8):637-46. PubMed ID: 24668783
[TBL] [Abstract] [Full Text] [Related]
17. Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase.
Shankar J; Kojic LD; St-Pierre P; Wang PT; Fu M; Joshi B; Nabi IR
J Cell Sci; 2013 Aug; 126(Pt 15):3295-304. PubMed ID: 23690547
[TBL] [Abstract] [Full Text] [Related]
18. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract] [Full Text] [Related]
19. Fasudil suppresses fibrosarcoma growth by stimulating secretion of the chemokine CXCL14/BRAK.
Miyamoto C; Maehata Y; Ozawa S; Ikoma T; Kubota E; Izukuri K; Kato Y; Hata R; Lee MC
J Pharmacol Sci; 2012; 120(3):241-9. PubMed ID: 23099322
[TBL] [Abstract] [Full Text] [Related]
20. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.
Ray-Coquard I; Blay JY; Italiano A; Le Cesne A; Penel N; Zhi J; Heil F; Rueger R; Graves B; Ding M; Geho D; Middleton SA; Vassilev LT; Nichols GL; Bui BN
Lancet Oncol; 2012 Nov; 13(11):1133-40. PubMed ID: 23084521
[TBL] [Abstract] [Full Text] [Related]
[Next]
